Worthington Announces the Availability of a New Digital Stem Cell Research Product Catalog at the International Symposium of Stem Cell Research

Enzymes specific for stem cell research are highlighted at the ISSCR 2022 Annual Meeting

LAKEWOOD, NJ (June 15, 2022) – Worthington announced today the release of a new digital stem cell product catalog for primary stem cell research and processing applications.

As an enzyme specialty company with a solid 75-year history, the Worthington name has become synonymous with the term “primary enzyme producer”. “This new applications-specific catalog is intended to assist researchers with the quick selection of enzymes and their related products”, said Cindy Santangelo, technical services director at Worthington. “We invite scientists to work with us hand-in-hand to enhance our stem cell research technical library by submitting protocols, citations and articles referencing Worthington enzymes that can be shared with their colleagues”.

Products highlighted in the catalog include Animal-free 
Collagenases, DNase 1, Papain, STEMxyme® Enzyme Blends and Neutral Protease.

About Worthington Biochemical Corporation

Founded in 1947, Worthington Biochemical Corporation is an industry leader in the development and production of high-quality purified enzymes, proteins, nucleic acids and cell isolation kits for life science research, diagnostics and biotechnology applications. An ISO9001 Certified, primary manufacturer Worthington meets enzyme requirements from research to scale-up bulk bioprocessing and OEM applications. Worthington Biochemical Corporation is a privately held company, headquartered in Lakewood, NJ and has worldwide distribution through a network of distributors.

For more information, contact:

Regina M Reynolds, VERISCOMM, LLC,
 323-929-9938 rr.veriscomm@icloud.com